DOCSLIB.ORG

Association Between Migraine and the Risk of Stroke: a Bayesian Meta-Analysis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Association Between Migraine and the Risk of Stroke: a Bayesian Meta-Analysis sustainability Review Association between Migraine and the Risk of Stroke: A Bayesian Meta-Analysis Kim-Ngan Ta-Thi 1,2, Kai-Jen Chuang 1,3,* and Chyi-Huey Bai 1,3 1 School of Public Health, College of Public Health, Taipei Medical University, Taipei 110, Taiwan; [email protected] (K.-N.T.-T.); [email protected] (C.-H.B.) 2 Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam 3 Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2736-1661 Abstract: There are still inconsistent results about association between migraine and stroke risk in studies. This paper was to review findings on the association between migraine (with or without aura) and stroke risk. We searched articles in the Embase and PubMed up to January 2021. Two independent reviewers extracted basic data from individual studies using a standardized form. Quality of studies was also assessed using the Newcastle–Ottawa Scale. We conducted a meta- analysis, both classical and Bayesian approaches. We identified 17 eligible studies with a sample size more than 2,788,000 participants. In the fixed effect model, the results demonstrated that migraine was positively associated with the risk of total stroke, hemorrhagic stroke, and ischemic stroke. Nevertheless, migraine was associated with only total stroke in the random effects model (risk ratio (RR) 1.31, 95%CI: 1.06–1.62). The probability that migraine increased total stroke risk was 0.978 (RR Citation: Ta-Thi, K.-N.; Chuang, 1.31; 95% credible interval (CrI): 1.01–1.72). All types of migraine were not associated with ischemic K.-J.; Bai, C.-H. Association between Migraine and the Risk of Stroke: A stroke and hemorrhagic stroke. Under three prior distributions, there was no association between Bayesian Meta-Analysis. migraine and the risk of ischemic stroke or hemorrhagic stroke. Under the non-informative prior and Sustainability 2021, 13, 3759. https:// enthusiastic prior, there was a high probability that migraine was associated with total stroke risk. doi.org/10.3390/su13073759 Keywords: migraine; ischemic stroke; hemorrhagic stroke; meta-analysis; Bayesian; headache Academic Editors: Grigorios L. Kyriakopoulos and Haywantee Ramkissoon 1. Introduction Received: 18 February 2021 Migraine and other headache disorders have become one of the leading causes of Accepted: 24 March 2021 disability since the Global Burden of Diseases, Injuries, and Risk Factors studies in 2000 Published: 28 March 2021 produced burden estimation of migraine worldwide. The results of Global Burden of Diseases, Injuries, and Risk Factors studies in 2016 also showed that headache, especially Publisher’s Note: MDPI stays neutral migraine, is a major global health issue in both male and female among all age groups with regard to jurisdictional claims in worldwide [1]. This affects not only employees’ health but also their productivity in published maps and institutional affil- iations. the labor sector, which acts as a deterrent for sustainable development of organizations and countries. According to Global and regional burden of disease and risk factors in 2001, cere- brovascular accidents (stroke) is the second leading cause of death and one of the ten leading causes of disease burden (measured in disability-adjusted life years—DALYs) Copyright: © 2021 by the authors. in both high-income countries and low-and-middle-income countries [2]. There are a Licensee MDPI, Basel, Switzerland. lot of risk factors related to stroke such as high blood pressure, older age, heart disease, This article is an open access article high cholesterol, smoking, atherosclerosis, diabetes, and a family history of stroke [3]. In distributed under the terms and conditions of the Creative Commons addition, the association between migraine and stroke has also received attention from Attribution (CC BY) license (https:// many researchers because preventive strategies to reduce the number of stroke patients creativecommons.org/licenses/by/ based on migraine status contribute to not only economic burden reduction of stroke for 4.0/). Sustainability 2021, 13, 3759. https://doi.org/10.3390/su13073759 https://www.mdpi.com/journal/sustainability Sustainability 2021, 13, 3759 2 of 12 public health systems, but also sustainable development at the individual, community, and national level. From 2004 to present, four previous meta-analyses on the association between mi- graine and stroke and one previous meta-analysis on the association between migraine and cardiovascular diseases drew inconsistent conclusions [4–8]. The latest meta-analysis of 18 cohort studies in 2017 found that migraine was associated with long-term risk of cere- brovascular events (both ischemic and hemorrhagic stroke) and cardiovascular events [5]. Since the publication date of that meta-analysis, several additional studies have examined the association between migraine and stroke and yielded contradictory findings with it [9–11]. Hence, a better understanding of association between stroke and migraine in gen- eral population is needed to take steps to reduce brain health problems in the Sustainable Development Goals. In this paper, we used both classical or frequentist (fixed effects and random effects models) meta-analysis and Bayesian meta-analysis. The classical approach, also frequentist statistics (proof of contradiction), has its own limitation in that the p-value is sensitive to sample size or sample size has an effect on the credibility of study results [12]. In addition, approximate 25% of the findings with a p-value less than 0.05 yielded false positive results [13,14]. Contrasting with the classical approach, the Bayesian approach applied the well-known Bayes theorem [15,16]. This approach does not depend on either sample size or p-value [17]. This inference method is an updated process by forming the “posterior information” based on “prior information” and the existing data from the study. In the frequentist approach, the p-value is the probability of the observed outcome given that the null hypothesis is true (Ho: there is no relationship between migraine and stroke), denoted by P (data observed | alternative hypothesis), or confidence interval is interpreted as 95% of random samples of study subjects will produce confidence intervals that contain the true proportion of migraine is associated with the risk of stroke. In contrast, Bayesian statistics aim to answer the question: Given the data we observed, what is the probability that some event of interest happens (i.e., the probability that migraine increases stroke risk at least 10%), which is denoted by P (event of interest | data observed). Therefore, the purpose of this study was to conduct a meta-analysis using the classical and Bayesian approaches to update the association between migraine and the risk of stroke. 2. Materials and Methods 2.1. Search Strategy and Selection Criteria The studies included in this analysis were from two sources: five previous meta- analyses and newly identified studies. The five previously published meta-analyses iden- tified 72 studies. We then conducted further searches for new studies that had been published since the publication of the latest meta-analysis in 2017. This search was con- ducted until January 2021 using the Embase and PubMed (during the last four years) with the following keywords: “stroke”, “migraine”, “cardiovascular diseases”, “headache”, and “Cerebrovascular accident”. The papers were included in the analysis based on the following criteria: (1) written in the English language; (2) studies on the human; (3) studies with clearly defined stroke as an outcome; (4) original papers; (5) studies reported risk ratio (RR) and its 95% confidence interval (CI); (6) cohort study design; and (7) migraine as the exposure of interest. In case of duplicate publications, the first published paper with data on the number of migraine and stroke cases were included. Studies would be excluded if data on migraine and stroke were not available and corresponding authors could not be contacted. In this paper, we included only cohort studies to evaluate long-term effects of migraine on stroke of large groups of individuals. Sustainability 2021, 13, 3759 3 of 12 2.2. Data Analysis Data Extraction and Quality Assessment Two reviewers (K.-N.T.-T. and K.-J.C.) independently examined papers or abstracts to extract basic data onto a standardized form. Any discrepancy between the two reviewers was resolved by verification of the third reviewer (C.-H.B). The Newcastle–Ottawa Scale, a validated scale, was used to assess the quality of nonrandomized studies (case-control and cohort studies) for each study [18]. In this scale, the cohort studies were assessed by three subscales: (a) selection, (b) comparability, and (c) outcome. Each subscale was rated maximum four, two, and three “stars” as scores respectively based on defined criteria [19]. A study with a total score of at least 7 was considered a high quality study [5]. 2.3. Meta-Analysis Classical meta-analysis was performed in both fixed-effect and random-effects models. In the Bayesian random-effects meta-analysis, we estimated the logarithm of relative risk- RR (denoted by θ) of each study and its variance (denoted by σ2). The result of this estimation was assumed to be normally distributed with overall effect of log RR for these studies (denoted by µ) and between-study variability τ2. Here, prior distribution for µ, σ2 and τ2 must be specific. The prior distribution for τ2 was assumed to be uniformly distributed with parameters (0, 10). Based on the Bayes theorem, we used three prior distributions below for µ and σ2 as described elsewhere [15,20,21]: Non-informative prior: It is hypothesized that the probabilities of migraine have a positive affect or a negative effect on stroke are equally likely. Therefore, overall RR was set with average 1, which means no effect of migraine on stroke (or average µ = 0) and variance as large as 10,000.
Load more

Recommended publications
  • Stand up to Chronic Migraine with Botox®
    #1 PRESCRIBED BRANDED TREATMENT FOR CHRONIC MIGRAINE* Chronic Migraine DON’T LIE DOWN BOTOX ® STAND UP TO Prevention CHRONIC MIGRAINE® WITH BOTOX Treatment Experience Treatment *Truven Health MarketScan Data, October 2010-April 2017. Prevent Headaches and Migraines Before They Even Start BOTOX ® BOTOX® prevents on average 8 to 9 headache days and migraine/probable migraine days a month (vs 6 to 7 for placebo) Savings Program For adults with Chronic Migraine, 15 or more headache days a month, each lasting 4 hours or more. BOTOX® is not approved for adults with migraine who have 14 or fewer headache days a month. Indication • Spread of toxin effects. The effect of botulinum toxin may affect areas BOTOX® is a prescription medicine that is injected to prevent headaches in adults away from the injection site and cause serious symptoms including: loss of with chronic migraine who have 15 or more days each month with headache strength and all-over muscle weakness, double vision, blurred vision and lasting 4 or more hours each day in people 18 years or older. drooping eyelids, hoarseness or change or loss of voice, trouble saying words It is not known whether BOTOX® is safe or effective to prevent headaches clearly, loss of bladder control, trouble breathing, trouble swallowing. in patients with migraine who have 14 or fewer headache days each month There has not been a confirmed serious case of spread of toxin effect away from (episodic migraine). the injection site when BOTOX® has been used at the recommended dose to IMPORTANT SAFETY INFORMATION treat chronic migraine. Resources BOTOX® may cause serious side effects that can be life threatening.
    [Show full text]
  • SOS – Save Our Shoulders: a Guide for Polio Survivors
    1 • Save Our Shoulders: A Guide for Polio Survivors A Guide for Polio Survivors S.O.S. Save Our Shoulders: A Guide for Polio Survivors by Jennifer Kuehl, MPT Roberta Costello, MSN, RN Janet Wechsler, PT Funding for the production of this manual was made possible by: The National Institute for Disability and Rehabilitation Research Grant #H133A000101 and The U.S. Department of the Army Grant #DAMD17-00-1-0533 Investigators: Mary Klein, PhD Mary Ann Keenan, MD Alberto Esquenazi, MD Acknowledgements We gratefully acknowledge the contributions and input provided from all of those who participated in our research. The time and effort of our participants was instrumental in the creation of this manual. Jennifer Kuehl, MPT Moss Rehabilitation Research Institute, Philadelphia Roberta Costello, MSN, RN Moss Rehabilitation Research Institute, Philadelphia Janet Wechsler, PT Moss Rehabilitation Research Institute, Philadelphia Mary Klein, PhD Moss Rehabilitation Research Institute, Philadelphia Mary Ann Keenan, MD University of Pennsylvania, Philadelphia Alberto Esquenazi, MD MossRehab Hospital, Philadelphia Cover and manual design by Ron Kalstein, MEd Albert Einstein Medical Center, Philadelphia Table of Contents 1. Introduction . .5 2. General Information About the Shoulder . .6 3. Facts About Shoulder Problems . .8 4. Treatment Options . .13 5. About Exercise . .16 6. Stretching Exercises . .19 7. Cane Stretches . .22 8. Strengthening Exercises . .25 9. Tips to Avoid Shoulder Problems . .29 10. Conclusion . .31 11. Resources . .31 The information contained within this manual is for reference only and is not a substitute for professional medical advice. Before beginning any exercise program consult your physician. Save Our Shoulders: A Guide for Polio Survivors • 4 Introduction Many polio survivors report new symptoms as they age.
    [Show full text]
  • Speech Sound Programme for 'K' / 'C' at the Start of Words
    Speech Sound Programme for ‘k’ / ‘c’ at the start of words This programme is for children who are producing a ‘t’ sound in place of a ‘k’ / ‘c’ sound at the start of words. For example, ‘cat’ is produced ‘tat’ and ‘cup’ is produced ‘tup’. ‘k’ is the target sound. ‘t’ is the produced sound. Below are a set of stages to work through with the child. Start with Stage 1 and only move up to the next stage when you are confident that the child has achieved the current stage. It is recommended that the programme is carried out for 15 minutes three times a week. If you would like any advice or you feel that the child is not making progress, please contact the Speech and Language Therapy team on 0151 514 2334. Stage 1 - Listening for the target sound 1. See ‘Picture Set 1’ for sound cue pictures that represent the target sound ‘k’ and the produced sound ‘t’. 2. Place the two pictures (‘k’ and ‘t’) in front of the child. 3. Teach the child the sounds, not the letter names, e.g., say ‘k’ and not ‘k-uh’. 4. Say the two sounds at random and ask the child to point or place a counter on which sound they hear. 5. Repeat this activity a number of times until you are sure the child can consistently hear the difference between the two sounds. Stage 2 - Sorting pictures by their first sound. 1. Now that the child can hear the difference between the two sounds (‘k’ and ‘t’) on their own, try the same with words.
    [Show full text]
  • The Migraine-Epilepsy Syndrome
    medigraphic Artemisaen línea Arch Neurocien (Mex) Vol 11, No. 4: 282-287, 2006 The Migraine- Epilepsy Syndrome Arch Neurocien (Mex) Vol. 11, No. 4: 282-287, 2006 Artículo de revisión ©INNN, 2006 de caso The migraine-epilepsy syndrome Enrique Otero Siliceo†, Fernando Zermeño EL SINDROME MIGRAÑA-EPILEPSIA represent a neural exitation. Since that the glutamate has in important rol in both patologys depending of the part of the brain more affected the symptoms might RESUMEN vary from visual to abdominal phemomena. La migraña y la epilepsia tienen varios puntos en común Key words: migraine epilepsy, EEG abnormalities, sintomática clínica y genéticamente lo que ha sido glutamate, diagnosis. postulado por más de cien años. El fenómeno referido como migraña-epilepsia sugiere que exista una he first steps of a practical, approach by patofisiología común. El síndrome de migraña o physicians in recognizing and treating neuro- epilepsia tiene fenómenos comunes de dolor adominal T logic diseases are to recognithat there are jaqueca anormalidades del EE y respuesta a droga various overlaps between migraine and epilepsy. antiepilépticas. En ocasiones el paciente puede tener Epileptic seizures and classic migraine episodes may un ataque migrañoso o una convulsión o en otras occur in the same patient. Migraine and epilepsy share ambas. La comorbilidad puede explicarse por estados several genetic, clinical, evolutive and neurophysio- de hiperrexcitabilidad neural. Alteraciones electroen- logic features. A relationship between epilepsy and cefalográficas son comunes en estos estados. En migraine has been postulated for over a hundred years apariencia el glutamato tiene un papel importante tanto and the syndrome of Migraine-Epilepsy illustrates this en la migraña como en la epilepsia.
    [Show full text]
  • Fatigue After Stroke
    SPECIAL REPORT Fatigue after stroke PJ Tyrrell Fatigue is a common symptom after stroke. It is not invariably related to stroke severity & DG Smithard† and can occur in the absence of depression. It is one of the most troublesome symptoms for †Author for correspondence many patients and yet nothing is known of its causation. There are no specific treatments. William Harvey Hospital, Richard Steven’s Ward, This article assesses the available literature in the context of what is known about fatigue Ashford, Kent, in other disorders. Post-stroke fatigue may be a manifestation of sickness behavior, TN24 0LZ, UK mediated through the central effects of the cytokine interleukin-1, perhaps via effects on Tel.: +44 123 361 6214 Fax: +44 123 361 6662 glutamate neurotransmission. Possible therapeutic strategies are discussed which might be [email protected] a logical basis from which to plan randomized control trials. Following stroke, approximately a third of common and disabling symptom of Parkinson’s patients die, a third recover and a third remain disease [7,8] and of systemic lupus [9]. More than significantly disabled. Even those who recover 90% of patients with poliomyelitis develop a physically may be left with significant emotional delayed syndrome of post-myelitis fatigue [10]. and psychologic dysfunction – including anxi- Fatigue is the most prevalent symptom of ety, readjustment reactions and depression. One patients with cancer who receive radiation, cyto- common but often overlooked symptom is toxic or other therapies [11], and it may persist fatigue. This may occur soon or late after stroke, for years after the cessation of treatment [12].
    [Show full text]
  • Journal of Neurological Disorders DOI: 10.4172/2329-6895.1000275 ISSN: 2329-6895
    olog eur ica N l D f i o s l o a r n d r e u r s o J Derakhshan, J Neurol Disord 2016, 4:4 Journal of Neurological Disorders DOI: 10.4172/2329-6895.1000275 ISSN: 2329-6895 Research Article Open Access Successful Opioid Monotherapy in Migralepsy: A Case Series Iraj Derakhshan* Department of Neurology, Case Western Reserve and Cincinnati Universities, Ohio, USA *Corresponding author: Iraj Derakhshan, Associate Professor, Department of Neurology, Case Western Reserve and Cincinnati Universities, Ohio, 205 Cyrus Drive, Charleston West Virginia, 25314, USA, Tel: 304 345 5174; E-mail: [email protected] Rec date: June 10, 2016; Acc date: July 06, 2016; Pub date: July 10, 2016 Copyright: © 2016 Derakhshan I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background: There is a consensus that migraine and epilepsy are comorbid conditions. The novel concept explored and developed in this case series is that of the primacy of headaches in generating seizures in those patients suffering from migraine-triggered epilepsy (i.e., migralepsy). As demonstrated in the five cases descried here, much like the effect of ketogenic-diet on migraine-triggered epilepsy, once the migraine headaches were completely suppressed after adopting daily scheduled opioid therapy the seizures stopped from occurring, but they returned with the recurrence of the migraines once the patients had stopped their daily opiate regimen for any reason. Clinical implications: The above pharmacological scenario is reminiscent of a similar but naturalistic course of events as described in reports concerning the salutary effects of ketogenic diet, or restoration of sleep, in cases of migraine-triggered epilepsy.
    [Show full text]
  • Changes in the Risk of Stroke in Dialysis Patients: a Retrospective Analysis Over the Last 40 Years
    toxins Article Changes in the Risk of Stroke in Dialysis Patients: A Retrospective Analysis over the Last 40 Years Toshiya Aono 1,†, Yuki Shinya 1,2,*,† , Satoru Miyawaki 2 , Takehiro Sugiyama 3,4, Isao Kumagai 5, Atsumi Takenobu 1, Masahiro Shin 2 , Nobuhito Saito 2 and Akira Teraoka 1 1 Department of Neurosurgery, Teraoka Memorial Hospital, Hiroshima 729-3103, Japan; [email protected] (T.A.); [email protected] (A.T.); [email protected] (A.T.) 2 Department of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan; [email protected] (S.M.); [email protected] (M.S.); [email protected] (N.S.) 3 Diabetes and Metabolism Information Center, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan; [email protected] 4 Department of Health Services Research, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan 5 Department of Nephrology, Teraoka Memorial Hospital, Hiroshima 729-3103, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-3-5800-8853 † These two authors have contributed equally to this study and are thus co-first authors. Abstract: The stroke incidence in hemodialysis (HD) patients is high, but the associated factors remain largely unknown. This study aimed to analyze stroke incidence in HD patients and changes in risk factors. Data of 291 patients were retrospectively analyzed. The cumulative stroke incidences were 21.6% at 10 years and 31.5% at 20. Diabetic nephropathy (DN) significantly increased overall stroke (hazard ratio (HR), 2.24; 95% confidence interval (CI), 1.21–4.12; p = 0.001) and ischemic p stroke (HR, 2.16; 95% CI, 1.00–4.64; = 0.049).
    [Show full text]
  • Migraine Mimics
    ISSN 0017-8748 Headache doi: 10.1111/head.12518 © 2015 American Headache Society Published by Wiley Periodicals, Inc. Expert Opinion Migraine Mimics Randolph W. Evans, MD The symptoms of migraine are non-specific and can be present in many other primary and secondary headache disorders, which are reviewed. Even experienced headache specialists may be challenged at times when diagnosing what appears to be first or worst, new type, migraine status, and chronic migraine. Key words: migraine, migraine mimic, symptomatic migraine, hemicrania continua (Headache 2015;55:313-322) The symptoms of migraine are non-specific and She had seen 2 headache specialists previously. can be present in many other primary and secondary She had been tried on sumatriptan p.o. and subcuta- headache disorders.1,2 Even experienced headache neously, diclofenac powder, ketorolac oral and intra- specialists may be challenged at times when diagnos- muscular, dihydroergotamine nasal spray, and had an ing what appears to be first or worst, new type, occipital nerve block without benefit. Gabapentin migraine status, and chronic migraine. Another diag- and pregabalin did not help. She was placed on indo- nosis may be responsible when physicians use the term methacin 75 mg sustained release once a day for 8 “atypical migraine.” days without benefit. Prednisone 60 mg daily for 10 days did not help.An intravenous dihydroergotamine CASE HISTORIES regimen for 5 days did not help. Case 1.—This 48-year-old woman was seen for a A magnetic resonance imaging (MRI) and mag- third opinion with a 20-year history of only menstrual netic resonance angiogram (MRA) of the brain and headaches always preceded by a visual aura followed cervical spine and magnetic resonance venogram by a generalized throbbing with an intensity of 5–6/10 (MRV) of the brain were negative.
    [Show full text]
  • Decreased Risk of Dementia in Migraine Patients with Traditional Chinese Medicine Use: a Population-Based Cohort Study
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 45), pp: 79680-79692 Clinical Research Paper Decreased risk of dementia in migraine patients with traditional Chinese medicine use: a population-based cohort study Chun-Ting Liu1,*, Bei-Yu Wu1,*, Yu-Chiang Hung1,2,*, Lin-Yi Wang3, Yan-Yuh Lee3, Tsu-Kung Lin4, Pao-Yen Lin5, Wu-Fu Chen6, Jen-Huai Chiang7,8, Sheng-Feng Hsu9,10 and Wen-Long Hu1,11,12,* 1Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and School of Traditional Chinese Medicine, Chang Gung University College of Medicine, Kaohsiung, Taiwan 2School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung, Taiwan 3Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan 4Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan 5Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan 6Department of Neurosurgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan 7Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan 8College of Medicine, China Medical University, Taichung, Taiwan 9Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan 10Department of Chinese Medicine, China Medical University Hospital, Taipei Branch, Taipei, Taiwan 11Kaohsiung Medical University College of Medicine, Kaohsiung, Taiwan 12Fooyin University College of Nursing, Kaohsiung, Taiwan *These authors contributed equally to this work Correspondence to: Wen-Long Hu, email: [email protected] Keywords: dementia, migraine, pharmaco-epidemiology, national health insurance research database, Chinese herbal product Received: February 27, 2017 Accepted: June 28, 2017 Published: July 08, 2017 Copyright: Liu et al.
    [Show full text]
  • Episodic Visual Snow Associated with Migraine Attacks
    Letters RESEARCH LETTER Discussion | Three patients report episodes of VS exclusively at the beginning or during migraine attacks. The description was Episodic Visual Snow Associated identical and matched the definition of VS in VSS except for With Migraine Attacks not being continuous.1,2 In the syndrome-defining study,1 only Visual snow syndrome (VSS) is a debilitating disorder charac- patients with continuous VS were included, impeding the iden- terized by continuous visual snow (VS), ie, tiny flickering dots tification of an episodic form. Based on the present case se- in the entire visual field resembling the view of a badly tuned ries, we propose to distinguish between VSS, a debilitating dis- analog television (Figure), plus additional visual symptoms, order characterized by continuous VS and additional visual such as photophobia and palinopsia. There is a high comor- symptoms persisting over years, and eVS, an uncommon self- 1 bidity with migraine and migraine aura. To our knowledge, limiting symptom during migraine attacks. this is the first report of patients with an episodic form of VS The relationship between migraine and VSS is still (eVS), strictly co-occurring with migraine attacks. unresolved.3 Although the severity of VS in VSS does not fluc- tuate in parallel to the migraine cycle,1 the strict co-occurrence Methods | Between January 2016 and December 2017, we saw of eVS and migraine reported here epitomizes a close proxim- 3 patients with eVS and 1934 patients with migraine at our ter- ity.This is in agreement with the clinical picture of migraine being tiary outpatient headache center.
    [Show full text]
  • Cluster Headacheheadache
    ClusterCluster HeadacheHeadache 1 OBJECTIVESOBJECTIVES Describe the clinical features and diagnosis of cluster headache Discuss the pathogenesis of cluster pain and autonomic features Review acute and preventive therapy Overview of new treatment horizons for refractory chronic cluster 2 IHSIHS CLASSIFICATIONCLASSIFICATION Cluster headache n Episodic type (80%) n Chronic type (20%) (Cluster period lasts for more than one year without remission or remission lasts less than 14 days) Episodic Chronic IHS Headache Classification Committee. Cephalalgia. 2004. Although the unique clinical features of cluster headache (CH) have been recognized since the 17th century, the striking periodicity was not articulated until the 1940s. The term “cluster headache” was coined in the 1950s, and since then the International Headache Society (IHS) has identified and classified two major temporal patterns of CH (1). The episodic type (ECH), by far the most common (90%), is characterized by discrete attack and remission phases. The chronic type (CCH) is defined by attacks that occur daily for more than one year without remission or with remission periods lasting less than 14 days. Cluster headache is rare (about 0.4% of the general population), and it predominates in males, although recent studies indicate that the rate in females is rising (2). Onset can occur at any age but usually begins between 30 and 50 years of age (3). In contrast to migraine headache, genetics in cluster headache is not thought to be important, although recent studies have shown a positive family history in about 7% of patients with cluster headache. When compared with prevalence of CH in the general population, first-degree relatives have about a 14-fold increased risk of developing CH.
    [Show full text]
  • Chemical Kinetics [A][B] [D] [C] [A][B] [B] [A] K R Dt D Dt D K R Dt D Dt D
    Chemical kinetics (Nazaroff & Alvarez-Cohen, Section 3.A.2) This is the answer to what happens when chemical equilibrium is not reached. For example, take the two-way reaction A + B ↔ C + D As A and B come into contact with each other, they start to react with each other, and the reaction rate can be expressed as Rforward = kf [A] [B]. This expression reflects the fact that the more of A and B there is, the more encounters occur, and the more reactions take place. This rate depletes the amounts of both A and B, and generates amounts of C and D: d[A] d[B] R k [A][B] dt dt forward f d[C] d[D] R k [A][B] dt dt forward f But, at the same time, C and D come in contact, too, and carry their own, reverse reaction, at a rate proportional to their amounts Rreverse = kr [C] [D] . This rate depletes the amounts of both C and D, and adds to the amounts of A and B: d[A] d[B] R k [C][D] dt dt reverse r d[C] d[D] R k [C][D] dt dt reverse r Because the two reactions occur simultaneously, we subtract the rate of one from the other: d[A] d[B] R R k [A][B] k [C][D] dt dt forward reverse f r d[C] d[D] R R k [A][B] k [C][D] dt dt forward reverse f r 1 Finally, in a system with open boundaries, we can add the imports and exports: d[A] V Qin [A]in Qout [A]out krV[C][D] kfV[A][B] dt inlets outlets d[B] V Qin [B]in Qout [B]out krV[C][D] kfV[A][B] dt inlets outlets d[C] V Qin [C]in Qout [C]out kfV[A][B] krV[C][D] dt inlets outlets d[D] V Qin [D]in Qout [D]out kfV[A][B] krV[C][D] dt inlets outlets imports exports sources sinks where V is the volume of the system for which the budget is written.
    [Show full text]